Abrdn Life Sciences Investors (HQL)

HQL Balance Sheet

Financials in millions USD. Fiscal year is October - September.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021
Cash & Equivalents	-	0.08	0	0	0	0
Cash & Short-Term Investments	-	0.08	0	0	0	0
Cash Growth	-	7553700.00%	-99.79%	7.19%	-55.05%	-
Accounts Receivable	1.27	1.14	0.23	5.04	0.62	0.15
Other Receivables	0.01	0.01	0.01	-	-	-
Receivables	1.28	1.15	0.24	5.04	0.62	0.15
Prepaid Expenses	0.05	0.04	0.04	0.03	0.03	0.03
Other Current Assets	-	-	-	15.24	11.09	8.47
Total Current Assets	1.33	1.26	0.28	20.31	11.74	8.64
Long-Term Investments	509.26	465.24	446.4	382.06	391.52	481.17
Other Long-Term Assets	52.63	48.88	13.9	0.23	11.47	44.37
Total Assets	563.23	515.38	460.58	402.6	414.73	534.19

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021
Accounts Payable	0.02	0.72	0	-	5.1	-
Accrued Expenses	0.74	0.57	0.84	0.67	0.63	0.7
Short-Term Debt	-	-	-	-	11.09	10.04
Other Current Liabilities	0.07	0.43	0.05	-	-	-
Total Current Liabilities	0.83	1.73	0.89	0.67	16.82	10.75
Other Long-Term Liabilities	1.57	-	-	-	-	-
Total Liabilities	2.4	1.73	0.89	0.67	16.82	10.75

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021
Common Stock	0.3	0.3	0.28	0.27	0.26	0.25
Additional Paid-In Capital	449.15	435.76	415.29	403.15	388.1	372.49
Retained Earnings	111.37	77.6	44.13	-1.48	9.55	150.7
Shareholders' Equity	560.83	513.66	459.69	401.93	397.9	523.44
Total Liabilities & Equity	563.23	515.38	460.58	402.6	414.73	534.19

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021
Total Debt	-	-	-	-	11.09	10.04
Net Cash (Debt)	-	0.08	0	0	-11.09	-10.04
Net Cash Growth	-	7553700.00%	-99.79%	-	-	-
Net Cash Per Share	-	0.00	-	0.00	-0.43	-0.41
Filing Date Shares Outstanding	30.41	29.6	28.06	26.79	25.68	24.67
Total Common Shares Outstanding	30.41	29.6	28.06	26.79	25.68	24.67
Working Capital	0.51	-0.46	-0.61	19.65	-5.08	-2.1
Book Value Per Share	18.44	17.35	16.38	15.00	15.49	21.22
Tangible Book Value	560.83	513.66	459.69	401.93	397.9	523.44
Tangible Book Value Per Share	18.44	17.35	16.38	15.00	15.49	21.22

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this fund.

Update frequency:

Semi-annually

Last checked:

Aug 1, 2026

Data Sources Report a data error